Bionime CorporationS7.A99About Bionime
Founded in 2003, Bionime is a global innovator in blood glucose management. We specialize in the research, design, manufacturing, and marketing of advanced solutions for personal and professional diabetes care, including Blood Glucose Meters (BGM), Continuous Glucose Monitoring systems (CGM), and Point-of-Care Testing (POCT).
iFree2 CGM
Bionime proudly presents the iFree2 CGM, a reliable and competitive Continuous Glucose Monitoring solution engineered for accuracy, sustainability, and user comfort. With up to 15 days of real-time glucose data, smart alerts, and an intuitive design, iFree2 CGM transforms glucose monitoring into a simpler and smarter experience.
RIGHTEST Diabetes Care Ecosystem
Under our proprietary RIGHTEST brand, Bionime delivers a cloud-based blood glucose management ecosystem powered by IoT digital solutions. By integrating product-generated medical data with customer service and market insights, RIGHTEST enables a human-centered, connected diabetes care experience with real-time data for smarter decision-making.
Global Presence
Headquartered in Taiwan, Bionime has established subsidiaries across four continents and works closely with a global distributor network spanning nearly 100 countries. Together, we deliver localized support and comprehensive solutions to meet the evolving needs of diabetes care worldwide.
